Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Jan 28, 2013 | SVP, GM - International | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 2,600 | $12.35 | 19,386 | |
Jan 28, 2013 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 838 | $12.35 | 25,093 | |
Jan 11, 2013 | Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,700 | $11.58 | 8,250 | |
Dec 17, 2012 | SVP and CT&OO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,000 | -- | 12,000 | |
Dec 17, 2012 | SVP and CT&OO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 7,512 | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 1,875 | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 3,050 | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 4,650 | |
Dec 10, 2012 | VP - Global Franchise | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 7,000 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.